Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-22-008595
Filing Date
2022-03-31
Accepted
2022-03-31 17:30:57
Documents
55
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1640937
2 ex31-1.htm EX-31.1 19475
3 ex32-1.htm EX-32.1 7724
  Complete submission text file 0001493152-22-008595.txt   5494826

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE foxw-20211231.xsd EX-101.SCH 40818
5 XBRL CALCULATION FILE foxw-20211231_cal.xml EX-101.CAL 44456
6 XBRL DEFINITION FILE foxw-20211231_def.xml EX-101.DEF 208208
7 XBRL LABEL FILE foxw-20211231_lab.xml EX-101.LAB 299424
8 XBRL PRESENTATION FILE foxw-20211231_pre.xml EX-101.PRE 249164
49 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 660965
Mailing Address 1 ROCKEFELLER PLAZA SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA SUITE 1039 NEW YORK NY 10020 917-284-8938
FoxWayne Enterprises Acquisition Corp. (Filer) CIK: 0001829999 (see all company filings)

EIN.: 853093926 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39891 | Film No.: 22794628
SIC: 2834 Pharmaceutical Preparations